This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pharmathen S.a.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Sotiria Haitidou
Introduction
Sotiria Haitidou is a notable inventor based in Pallini Attikis, Greece. She has made significant strides in the field of pharmaceutical technology, particularly in the preparation of biodegradable microparticles. Her work focuses on enhancing the release profiles of active pharmaceutical compounds, which is crucial for effective drug delivery.
Latest Patents
Sotiria Haitidou holds a patent for the "Preparation of polylactide-polyglycolide microparticles having a sigmoidal release profile." This invention relates to the creation of biodegradable microparticles formed from polylactide-polyglycolide copolymers (PLGA). The innovative process involves emulsification of an inner/oil phase into an outer/water phase, followed by quenching and a single drying step. This method allows for the controlled release of active pharmaceutical compounds, particularly basic/nucleophilic compounds like risperidone. The release profile can be finely tuned by adjusting various parameters, including the saturation of the outer phase and the temperature during quenching.
Career Highlights
Sotiria is currently employed at Pharmathen S.A., where she continues to contribute to advancements in pharmaceutical formulations. Her expertise in microparticle technology has positioned her as a valuable asset in her field.
Collaborations
Throughout her career, Sotiria has collaborated with esteemed colleagues such as Evangelos Karavas and Efthymios Koutris. These partnerships have fostered innovation and have been instrumental in the development of her patented technologies.
Conclusion
Sotiria Haitidou's contributions to the field of pharmaceutical technology exemplify the impact of innovative thinking in drug delivery systems. Her work not only advances scientific knowledge but also enhances the efficacy of medications, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile